<SEC-DOCUMENT>0001104659-18-020444-index.html : 20180327 <SEC-HEADER>0001104659-18-020444.hdr.sgml : 20180327 <ACCEPTANCE-DATETIME>20180327160547 ACCESSION NUMBER: 0001104659-18-020444 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180321 FILED AS OF DATE: 20180327 DATE AS OF CHANGE: 20180327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schranz Jennifer CENTRAL INDEX KEY: 0001735382 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 18715449 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>3 <SEQUENCE>1 <FILENAME>a3.xml <DESCRIPTION>3 <TEXT> Document 1 - file: a3.html
Document 1 - RAW XML: a3.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-24 <SEQUENCE>2 <FILENAME>ex-24.htm <DESCRIPTION>EX-24 <TEXT> Document 2 - file: ex-24.htm
</DOCUMENT> </SEC-DOCUMENT>